Measurable residual disease (MRD)-testing in haematological and solid cancers.

Chen, Junren; Gale, Robert Peter; Hu, Yu; Yan, Wen; Wang, Tiantian; Zhang, Wei

Chen, Junren; Gale, Robert Peter; Hu, Yu; Yan, Wen; Wang, Tiantian; Zhang, Wei.

Affiliation

Chen J; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China. chenjunren@ihcams.
Gale RP; Tianjin Institutes of Health Science, Tianjin, China. chenjunren@ihcams.ac.cn.
Hu Y; Centre for Haematology, Department of Immunology and Inflammation, Imperial College of Science, Technology and Medicine, London, UK.
Yan W; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China.
Wang T; Tianjin Institutes of Health Science, Tianjin, China.
Zhang W; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China.

Leukemia ; 38(6): 1202-1212, 2024 Jun.

Article in En | MEDLINE | ID: mdl-38637690

Subject(s)

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Neoplasm, Residual / Hematologic Neoplasms / Neoplasms Limits: Humans Language: En Journal: Leukemia Journal subject: HEMATOLOGIA / NEOPLASIAS Year: 2024 Document type: Article Affiliation country: China Country of publication: Reino Unido

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google